Skip to main content
Clinical Trials/NL-OMON54518
NL-OMON54518
Recruiting
Phase 3

Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure: a randomized trial (TAVR-UNLOAD) - TAVR-UNLOAD

Cardiovascular Research Foundation (CRF)0 sites56 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
aorta stenose
Sponsor
Cardiovascular Research Foundation (CRF)
Enrollment
56
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Cardiovascular Research Foundation (CRF)

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \>\=18 years
  • 2\. Heart failure with NYHA class \>\= 2
  • 3\. Under appropriate and stable guideline\-directed HF therapy for a minimum of
  • 1 month prior to randomization. Note: Patients are expected to be on
  • appropriate pharmacologic therapy and if indicated CRT for heart failure. (12,
  • 13\) Patients with aortic stenosis may not be able to tolerate maximal doses of
  • heart failure medications and no specific guidelines exist for the medical
  • treatment of heart failure in the setting of aortic stenosis. It is expected
  • that the heart failure PI will review the medical therapy and confirm that it
  • is appropriate for the patient\*s condition.

Exclusion Criteria

  • 1\. LVEF \< 20% or persistent need for intravenous inotropic support
  • 2\. Hospitalization for acute decompensated HF within 2 weeks prior to
  • randomization
  • 3\. Cardiac resynchronization therapy (CRT) device implantation within 1 month
  • prior to randomization
  • 4\. Coronary artery revascularization (PCI or CABG) within 1 month prior to
  • randomization
  • 5\. In need and suitable for revascularization per heart team consensus
  • 6\. Severe aortic and/or mitral regurgitation
  • 7\. Congenital unicuspid or congenital bicuspid aortic valve

Outcomes

Primary Outcomes

Not specified

Similar Trials